These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1528947)

  • 21. The effects of MIF-I, beta-endorphin and alpha-MSH on d-amphetamine induced paradoxical behavioral thermoregulation: possible involvement of the dopaminergic system.
    Yehuda S; Sheleff P
    Peptides; 1985; 6(2):189-92. PubMed ID: 2863810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of d-amphetamine and morphine on discrimination: signal detection analysis and assessment of response repetition in the performance deficits.
    Koek W; Slangen JL
    Psychopharmacology (Berl); 1983; 80(2):125-8. PubMed ID: 6410439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
    Negus SS; Gatch MB; Mello NK
    Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential attenuation of d-amphetamine-induced disruption of conditional discrimination performance by dopamine and serotonin antagonists.
    Dunn MJ; Killcross S
    Psychopharmacology (Berl); 2006 Oct; 188(2):183-92. PubMed ID: 16944104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphetamine discrimination: onset of the stimulus.
    Silverman PB; Ho BT
    Pharmacol Biochem Behav; 1980 Feb; 12(2):303-4. PubMed ID: 7375493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulus effects of d-amphetamine 1: DA mechanisms.
    Van Groll BJ; Appel JB
    Pharmacol Biochem Behav; 1992 Nov; 43(3):967-73. PubMed ID: 1360165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of effects of dopaminergic agonists on neuronal activity in the caudate-putamen of the rat following long-term d-amphetamine administration.
    Rebec GV; Groves PM
    Pharmacol Biochem Behav; 1976 Sep; 5(3):349-57. PubMed ID: 996066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitatory and inhibitory actions of morphine on the discriminative stimulus properties of D-amphetamine.
    Gaiardi M; Bartoletti M; Gubellini C
    Pharmacol Res; 1998 Nov; 38(5):333-7. PubMed ID: 9806811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.
    Schad CA; Justice JB; Holtzman SG
    J Pharmacol Exp Ther; 2002 Mar; 300(3):932-8. PubMed ID: 11861800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine discrimination: effects of dopamine receptor agonists.
    Nielsen EB; Randrup K; Andersen PH
    Eur J Pharmacol; 1989 Jan; 160(2):253-62. PubMed ID: 2569406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Jan; 12(1):1-5. PubMed ID: 6102768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of d-amphetamine-induced disruption of conditional discrimination performance by alpha-flupenthixol.
    Dunn MJ; Futter D; Bonardi C; Killcross S
    Psychopharmacology (Berl); 2005 Jan; 177(3):296-306. PubMed ID: 15448975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.
    Quisenberry AJ; Baker LE
    Psychopharmacology (Berl); 2015 Dec; 232(24):4411-9. PubMed ID: 26374456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)PPAP: a new and selective ligand for sigma binding sites.
    Glennon RA; Battaglia G; Smith JD
    Pharmacol Biochem Behav; 1990 Nov; 37(3):557-9. PubMed ID: 1965044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of training paradigm on specificity of drug mixture discriminations.
    Mariathasan EA; Stolerman IP; White JA
    Pharmacol Biochem Behav; 1999 Oct; 64(2):409-13. PubMed ID: 10515322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of generalization of nisoxetine with amphetamine in the rat.
    Schechter MD; Boja JW
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1085-8. PubMed ID: 3265789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.